The Scotts Miracle-Gro Company (SMG) Profit Margins
Over the twelve months to 2026-06-30, The Scotts Miracle-Gro Company (SMG) had gross margin 31.8%, operating margin 11.0%, net margin 2.1%, free cash flow margin 7.6%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SMGThe Scotts Miracle-Gro CompanyFollow SMG — free
—
Price chart with a free account
- Market cap
- 3.5B
- P/E TTM
- 50.2
- Dividend yield
- 4.5%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2010 Sep 10 | FY2011 Sep 11 | FY2012 Sep 12 | FY2013 Sep 13 | FY2014 Sep 14 | FY2015 Sep 15 | FY2016 Sep 16 | FY2017 Sep 17 | FY2018 Sep 18 | FY2019 Sep 19 | FY2020 Sep 20 | FY2021 Sep 21 | FY2022 Sep 22 | FY2023 Sep 23 | FY2024 Sep 24 | FY2025 Sep 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 37.8% | 36.0% | 34.5% | 35.3% | 34.5% | 34.2% | 35.9% | 36.8% | 32.5% | 32.3% | 32.6% | 29.8% | 22.2% | 18.5% | 23.9% | 30.6% | 31.8% | |
| Operating margin | 13.0% | 9.8% | 8.7% | 11.2% | 11.0% | 10.7% | 17.9% | 16.4% | 7.5% | 13.0% | 14.2% | 14.7% | -11.1% | -4.9% | 5.9% | 10.5% | 11.0% | |
| Net margin | 7.1% | 6.0% | 3.8% | 5.8% | 6.5% | 6.7% | 12.6% | 8.3% | 2.4% | 14.6% | 9.4% | 10.4% | -11.1% | -10.7% | -1.0% | 4.3% | 2.1% | |
| FCF margin | 7.4% | 1.8% | 3.0% | 10.2% | 5.9% | 7.8% | 7.4% | 11.1% | 10.3% | 5.8% | 12.0% | 3.3% | -6.2% | 12.3% | 16.4% | 8.0% | 7.6% |
USD billions · SEC XBRL
The Scotts Miracle-Gro Company — questions
- What is The Scotts Miracle-Gro Company's gross margin?
- 31.8% over the twelve months to 2026-06-30.
- What is The Scotts Miracle-Gro Company's operating margin?
- 11.0% over the twelve months to 2026-06-30.
- What is The Scotts Miracle-Gro Company's net profit margin?
- 2.1% over the twelve months to 2026-06-30.
Every figure on this page comes from The Scotts Miracle-Gro Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.